Skip to main content
SpringerLink
Log in

CV disorder risks extend beyond COX-2-selectivity of NSAIDs

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Graham DJ, Singh G, Wang H, Mannalithara A, Lingala V, Mithal A, Triadafilopoulos G.Risk of stroke in arthritis patients treated with Cox-2 selective and non-selective NSAIDs. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 67, Aug 2007

    Google Scholar 

  2. Haag M, Breteler M, Stricker B.COX-selectivity of nonsteroidal antiinflammatory drugs and the risk of stroke. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 67-68, Aug 2007

  3. Miller DR, Kaufman DW, Lewis MA, Rahme E, Rosenberg L, Lelorier J, Cunningham F.NSAID use and risk of myocardial infarction in U.S. veterans. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 68, Aug 2007

  4. Lewis MA, Miller DR, Rahme E, Kühl-Habich D, Cunningham F, Kaufman DW, Rosenberg L, Lelorier J.Use of Cox-2 inhibitors, other NSAIDs, and the risk of myocardial infarction in three populations from UK, Canada, and the US. Pharmacoepidemiology and Drug Safety 16 (Suppl. 2): 68-69, Aug 2007

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CV disorder risks extend beyond COX-2-selectivity of NSAIDs. React. Wkly. 1170, 3 (2007). https://doi.org/10.2165/00128415-200711700-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711700-00006

Keywords

Search

Navigation